IMRIS to hold annual and fourth quarter 2008 results conference call on February 25, 2009

    WINNIPEG, Feb. 19, 2009 /CNW/ - IMRIS Inc. (TSX: IM)

    
    -------------------------------------------------------------------------
    Annual and Fourth Quarter 2008      February 25, 2009
    Earnings Release
    -------------------------------------------------------------------------
    Conference Call and Webcast         February 25, 2009, 4:30 p.m. ET
                                        (3:30 p.m. CT)
    -------------------------------------------------------------------------
    Hosted by                           David Graves, Chairman, President and
                                        Chief Executive Officer
                                        Ron Sabourin, Executive Vice
                                        President, Finance & Administration
                                        and Chief Financial Officer
    -------------------------------------------------------------------------
    Participant Numbers                 416-644-3423 or 1-800-731-5774
    -------------------------------------------------------------------------
    

    A question and answer session for analysts and institutional investors
will follow management's presentation. To access the live audio webcast,
please visit IMRIS' website at www.imris.com. A taped rebroadcast will be
available to listeners until 12 a.m. ET on March 4, 2009. To access the
rebroadcast, please dial 416-640-1917 or 1-877-289-8525 and enter the passcode
21298797 followed by the number sign.

    About IMRIS

    IMRIS (TSX: IM) is a global leader in providing fully integrated,
advanced surgical imaging solutions designed to measurably improve patient
outcomes. The company's flagship product, IMRISneuro, utilizes patented
technology that allows a high field MRI scanner to move in to the operating
room on demand, providing imaging during the surgical procedure without
compromising patient safety. This unique and innovative system has been
validated by leading neurosurgeons around the world for use in world-class
neuroscience centers.

    For more information, visit www.imris.com

For further information:

For further information: Brad Woods, Investor Relations, IMRIS Inc.,
Tel: (204) 480-7094, Email: bwoods@imris.com